Recombinant bacterium capable of producing L-homoserine at high yield as well as preparation method and application of recombinant bacterium

A technology of homoserine and recombinant bacteria, applied in the biological field, can solve the problems of unfriendly environment, lack of homoserine, and high cost, and achieve the effect of realizing reducing power balance and enhancing glyoxylic acid cycle.

Active Publication Date: 2021-07-16
INST OF MICROBIOLOGY - CHINESE ACAD OF SCI
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The chemical method is unfriendly to the environment and has high cost because of the use of iodide and the generation of sulfide; the enzymatic method uses pyruvate and formaldehyde to generate homoserine under the combined action of aldolase and L-amino acid dehydrogenase. The main problem of the process is still the high cost, the use of toxic raw materials formaldehyde and formic acid, and the use of expensive coenzymes, etc.; the microbial fermentation method has the advantages of low cost, mild conditions, and environmental protection, but because homoserine has an inhibitory effect on microbial growth , so there are still no reports of higher yields of homoserine at home and abroad

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant bacterium capable of producing L-homoserine at high yield as well as preparation method and application of recombinant bacterium
  • Recombinant bacterium capable of producing L-homoserine at high yield as well as preparation method and application of recombinant bacterium
  • Recombinant bacterium capable of producing L-homoserine at high yield as well as preparation method and application of recombinant bacterium

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0079] Embodiment 1, inventive thinking

[0080] The dual-channel 1:1 ratio is used to achieve cofactor balance, as follows:

[0081] Cofactor balance is a very important factor in the process of metabolic pathway modification. The imbalance of cofactors will cause the disadvantages of slow cell growth and low product yield. In the present invention, taking the metabolic pathways of homoserine and threonine as an example, there are two pathways in Escherichia coli to generate L-homoserine and L-threonine. The first is the conventional oxaloacetate synthesis aspartic acid route, under anaerobic conditions, the theoretical conversion ratio from glucose to product is 1:2, but it lacks the reducing power of 4 NADPH: 1 Glucose+6 NADPH +2 CO2+2ATP=2 Homoserine / Threonine+2 NADH; the second way is to knock out the glyoxylate cycle inhibitor gene iclR, enhance the glyoxylate cycle of E. Express the aspA gene, enhance the synthesis ability of fumaric acid to aspartic acid, the theore...

Embodiment 2

[0082] Example 2, Construction of chassis strains MG1655 (△lacI, △thrB::Trc-ppc, △metA, △lysA, △sthA::Trc-pntAB)

[0083] Using Crispr / cas9 technology to knock out, replace or insert genes on the MG1655 chromosome, the construction of the chassis strain mainly includes: knocking out the threonine metabolism pathway homoserine kinase thrB, knocking out the methionine metabolism bypass homoserine succinyltransferase metA, Knockout of lysine metabolism bypass diaminoheptanoate decarboxylase lysA, knockout of glyoxylate pathway inhibitory protein iclR, overexpression of phosphoenolpyruvate carboxylase ppc, knockout of soluble pyridine nucleotidyl transferase sthA, Overexpression of the pyridine nucleotidyl transferase pntAB, as follows:

[0084] 1. Knockout of the DNA-binding transcriptional repressor lacI (NP_414879.3, submission date 20181011)

[0085] 1. Construction of MG1655 / pCAS

[0086] The pCAS plasmid (kanamycin resistance) was introduced into MG1655. Because the pCAS p...

Embodiment 3

[0129] Example 3, Preparation of recombinant bacteria overexpressing thrA* and asd and its application in improving homoserine production

[0130] 1. Preparation of recombinant bacteria overexpressing thrA* and asd

[0131] The commercial plasmid pTRC99A was used to overexpress aspartokinase I mutant thrA* (1034C-T) and aspartate semialdehyde dehydrogenase asd to increase the flux from aspartic acid to homoserine; the specific method is as follows:

[0132] pTRC99A was double digested with NcoI and HindIII, and the 4120bp pTRC99A digestion product was collected.

[0133] Using MG165 genomic DNA as a template, amplify respectively with primers thrA-F / R and asd-F / R (Table 2), obtain the thrA gene of 2463bp (the nucleotide sequence is compared with sequence 8, only the 1034 base C, other bases are the same) and the 1104bp asd gene (SEQ ID NO: 9).

[0134] The above-mentioned 4120bp pTRC99A digestion product, 2463bp thrA gene and 1104bp asd gene were ligated using Gibson seamles...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a recombinant bacterium capable of producing L-homoserine at high yield as well as a preparation method and application of the recombinant bacterium. The recombinant bacterium provided by the invention is obtained by transforming the following two ways A) and B) in a chassis host bacterium: A) a metabolic way from fumaric acid to aspartic acid in the chassis host bacterium is enhanced, so that the metabolic flow of the two ways from oxaloacetic acid to L-aspartic acid and the metabolic flow of the two ways from fumaric acid to L-aspartic acid are matched in a ratio of 1: 1; and B) a metabolic pathway from aspartic acid to homoserine in the chassis host bacteria is enhanced; The method has the following advantages: 1, the iclR gene is knocked out; 2, an L-homoserine efflux pump gene rthB is used; and 3, two synthesis routes of L-aspartic acid, namely an oxaloacetic acid OAA synthesis route and a fumaric acid FUM synthesis route, are accurately regulated and controlled, so that the two synthesis fluxes are matched in a ratio of 1: 1, the reduction force balance in the fermentation process of the L-homoserine is realized, and the yield of the L-homoserine is maximized.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to a recombinant bacterium with high production of L-homoserine and its preparation method and application. Background technique [0002] L-homoserine (L-homoserine) is a naturally occurring non-protein amino acid, which exists in a small amount in many species as a common intermediate in the biosynthesis of threonine, methionine and lysine. Since L-homoserine has an L-type-α amino acid basic skeleton, and its γ-hydroxyl has various chemical activities, L-homoserine and its derivatives have important applications in pharmaceuticals and physiology as pharmaceutical intermediates. prospect. As a precursor of threonine, homoserine has similarities in the transformation of metabolic pathways. [0003] At present, there are mainly three methods for producing L-homoserine at home and abroad: chemical method, enzyme catalysis and microbial fermentation. The chemical method is un...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N1/21C12N15/70C12N15/77C12N15/75C12N15/78C12P13/08C12P13/06C12R1/19C12R1/15C12R1/07C12R1/38
CPCC12N9/88C12N9/1217C12N9/0008C12Y207/02004C12Y102/01011C12Y403/01001C12N15/70C12N15/77C12N15/75C12N15/78C12P13/08C12P13/06
Inventor 牟庆璇张莎莎王丽敏陶勇于波
Owner INST OF MICROBIOLOGY - CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products